# ChatGPT Response

The variant rs113488022 is located in the BRAF gene on chromosome 7 at position 140753336. This gene encodes a protein that plays a key role in the MAPK/ERK signaling pathway, which is critical for cell division, differentiation, and survival. Variations in this gene have been associated with various clinical phenotypes.

### Disease Associations (1-2):
1. **RASopathy:** Associated with pathogenic interpretation in ClinVar. RASopathies are a group of syndromes caused by mutations in genes in the Ras/MAPK pathway.
   - ClinVar Variation ID: [VCV000040389](https://www.ncbi.nlm.nih.gov/clinvar/variation/40389)

2. **Melanoma:** The variant has a pathogenic interpretation in relation to melanoma, highlighting its role in oncogenesis. It is associated with significant gain-of-function mutations in BRAF.
   - ClinVar Variants:
     - [VCV000040389](https://www.ncbi.nlm.nih.gov/clinvar/variation/40389)
     - [VCV000376288](https://www.ncbi.nlm.nih.gov/clinvar/variation/376288)

3. **Cardio-facio-cutaneous Syndrome:** This syndrome is linked to this variant with interpretations ranging from likely pathogenic to uncertain significance. This condition involves congenital anomalies and developmental delays.
   - ClinVar Variation ID: [VCV000040389](https://www.ncbi.nlm.nih.gov/clinvar/variation/40389)

4. **Colon and Thyroid Cancers:** Another notable pathogenic association of this variant is in cancers such as squamous cell carcinoma of the colon and papillary thyroid carcinoma. This may be due to its role in activating the MAPK/ERK signaling pathway.

### Functional Predictions:
- **SIFT Score:** 0.0 (Deleterious prediction)
- **Polyphen Score:** Ranges from 0.294 to 0.958, with some transcripts indicating high pathogenic impact.
- **AlphaMissense Score:** Values such as 0.9773 and 0.9748 indicate a strong likelihood of this variant affecting protein function.

### Population Genetics (1-4):
- Unfortunately, allele frequency data in Japanese and non-Japanese populations are not detailed. However, the variant has been found to have a low frequency globally:
  - gnomAD Exomes: **AF = 1.37e-06**

### Transcripts and Clinical Relevance (1-1):
Multiple transcripts and HGVS annotations describe this variation:
1. **ENST00000288602.11:c.1919T>G / p.Val640Gly**
2. **ENST00000496384.7:c.1799T>G / p.Val600Gly**

The specific p.Val600Gly (V600G) change, frequently reported in the context of cancer, is well-known for its activating mutation, driving uncontrolled cellular growth.

### Relevant Literature (1-3):
- The variant appears in studies related to cancer progression and RASopathy-associated phenotypes. It has been emphasized in melanoma and developmental syndrome literature for its role in hyper-activating MAPK pathway signaling.
  - [DBSNP rs113488022](https://identifiers.org/dbsnp/rs113488022)

### GWAS (1-5):
Although specific GWAS studies linking this variant to new phenotypes are unavailable, the mechanistic insights suggest its widespread role in cancers and certain congenital syndromes.

### TogoVar API (1-6):
You can explore more details on TogoVar using the following link:
[TogoVar rs113488022](https://togovar.biosciencedbc.jp/variant/tgv417516613)

### Summary:
The location of rs113488022 within the protein kinase domain of BRAF influences clinical phenotypes by enhancing MAPK/ERK pathway signaling. This hyperactivation is implicated mainly in oncology (e.g., melanoma, colon carcinoma) and developmental disorders (e.g., RASopathies).